Home / Brands / Shire Human Genetic Therapies
Shire Human Genetic Therapies Recalls
5 recalls on record · April 30, 2014 to October 2, 2019 · Drugs
Recalls by year
14
19
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
October 2, 2019DrugsFDA
Shire Human Genetic Therapies, Inc. recalls Natpara (parathyroid hormone) for Injection, 100 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only,
Hazard: Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
October 2, 2019DrugsFDA
Shire Human Genetic Therapies, Inc. recalls Natpara (parathyroid hormone) for Injection, 75 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only, M
Hazard: Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
October 2, 2019DrugsFDA
Shire Human Genetic Therapies, Inc. recalls Natpara (parathyroid hormone) for Injection, 50 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only, M
Hazard: Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
October 2, 2019DrugsFDA
Shire Human Genetic Therapies, Inc. recalls Natpara (parathyroid hormone) for Injection, 25 mcg/dose, 2 pack cartridges, Rx only, For subcutaneous use only, Manufac
Hazard: Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
April 30, 2014DrugsFDA
Shire Human Genetic Therapies, Inc. recalls VPRIV¿ (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only. Shire Human Genetic Therapies,
Hazard: Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate.